bupropion risk_factor_for abstinence
Evidence from:
primary |
all sources
Evidence (1 sources)
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation.
(2008)
PMID:18593715
cited
individuals carrying the minor allele who had received bupropion ... had the greatest reduction in abstinence once treatment ended (22.4% at EOT to 10.6% at 6‑month).
confidence: 0.60